Bibliographie (2546)
Review: COVID-19-associated Invasive Fungal Infection.
mercredi, 24 novembre 2021 09:51 Écrit par Zouhair SouissiCOVID-19-associated Invasive Fungal Infection – Open Forum Infectious Diseases Related: Taskforce report on the diagnosis and clinical management of COVID-19 associated pulmonary aspergillosis. M-A: Incidence and mortality of COVID‐19‐associated pulmonary aspergillosis – The incidence and mortality in the ICU were estimated to be 10.2% and 54.9%, respectively. Consensus Guideline: Defining and managing COVID-19-associated pulmonary aspergillosis […]
The post Review: COVID-19-associated Invasive Fungal Infection. appeared first on Links Medicus.
We expected people with asthma to fare worse during COVID. Turns out they’ve had a break.
mercredi, 24 novembre 2021 09:51 Écrit par Zouhair SouissiWe expected people with asthma to fare worse during COVID. Turns out they’ve had a break – The Conversation
The post We expected people with asthma to fare worse during COVID. Turns out they’ve had a break. appeared first on Links Medicus.
Populational study in France did not show an increased incidence of acute myocardial infarction, stroke, and pulmonary embolism following the Pfizer vaccine.
mardi, 23 novembre 2021 10:02 Écrit par Zouhair SouissiMyocardial Infarction, Stroke, and Pulmonary Embolism After BNT162b2 mRNA COVID-19 Vaccine in People Aged 75 Years or Older – JAMA
The post Populational study in France did not show an increased incidence of acute myocardial infarction, stroke, and pulmonary embolism following the Pfizer vaccine. appeared first on Links Medicus.
![[Preprint] Systematic Review: Duration of Effectiveness of Vaccines Against SARS-CoV-2 Infection and COVID-19 Disease – “effectiveness against COVID-19 severe disease remained high (>70%) in most studies in the six months after full vaccination, although](/media/k2/items/cache/758dc7ab63677117467388c3b99fce90_M.jpg)
[Preprint] Systematic Review: Duration of Effectiveness of Vaccines Against SARS-CoV-2 Infection and COVID-19 Disease – “effectiveness against COVID-19 severe disease remained high (>70%) in most studies in the six months after full vaccination, although
mardi, 23 novembre 2021 10:02 Écrit par Zouhair SouissiDuration of Effectiveness of Vaccines Against SARS-CoV-2 Infection and COVID-19 Disease: Results of a Systematic Review and Meta-Regression – Preprints with The Lancet – SSRN Related: Correlation of SARS-CoV-2-breakthrough infections to time-from-vaccine. China’s COVID vaccines have been crucial — now immunity is waning. [Preprint] Breakthrough SARS-CoV-2 infections in 620,000 U.S. Veterans, February 1, 2021 to […]
The post [Preprint] Systematic Review: Duration of Effectiveness of Vaccines Against SARS-CoV-2 Infection and COVID-19 Disease – “effectiveness against COVID-19 severe disease remained high (>70%) in most studies in the six months after full vaccination, although it did decrease some (on average, 8-10 percentage points) between one and six months after full vaccination”. appeared first on Links Medicus.
M-A: Colchicine doesn’t lessen COVID-19 severity or stave off risk of death.
mardi, 23 novembre 2021 10:02 Écrit par Zouhair SouissiNews release: Gout drug colchicine doesn’t lessen COVID-19 severity or stave off risk of death – BMJ Original Study: Efficacy and safety of colchicine in COVID-19: a meta-analysis of randomised controlled trials – RMD Open Related: RECOVERY Trial: In patients admitted to hospital with COVID-19, Colchicine did not reduce 28-day mortality, duration of hospital stay, […]
The post M-A: Colchicine doesn’t lessen COVID-19 severity or stave off risk of death. appeared first on Links Medicus.
Estimation of SARS-CoV-2 infection fatality rate by age and comorbidity status using antibody screening of blood donors during the COVID-19 epidemic in Denmark – “The IFR was low for people younger than 51 years without comorbidity during the two waves (c
lundi, 22 novembre 2021 02:38 Écrit par Zouhair SouissiEstimation of SARS-CoV-2 infection fatality rate by age and comorbidity status using antibody screening of blood donors during the COVID-19 epidemic in Denmark – The Journal of Infectious Diseases Commentary on Twitter New in JID: A study in Denmark found that the SARS-CoV-2 infection fatality rate was low for people younger than 51 and […]
The post Estimation of SARS-CoV-2 infection fatality rate by age and comorbidity status using antibody screening of blood donors during the COVID-19 epidemic in Denmark – “The IFR was low for people younger than 51 years without comorbidity during the two waves (combined IFR = 3.36 per 100,000 infections)”. appeared first on Links Medicus.
M-A: Convalescent plasma does not reduce mortality in COVID-19.
lundi, 22 novembre 2021 02:38 Écrit par Zouhair SouissiAssociation between convalescent plasma treatment and mortality in COVID-19: a collaborative systematic review and meta-analysis of randomized clinical trials – BMC Infectious Diseases Related: RCT: Another study shows convalescent plasma does not improve outcomes in critically ill patients with Covid-19. RCT: Convalescent plasma does not improve outcomes and may be harmful to hospitalized patients with […]
The post M-A: Convalescent plasma does not reduce mortality in COVID-19. appeared first on Links Medicus.
Is Delta the last Covid ‘super variant’?
lundi, 22 novembre 2021 02:38 Écrit par Zouhair SouissiIs Delta the last Covid ‘super variant’? – The Guardian
The post Is Delta the last Covid ‘super variant’? appeared first on Links Medicus.
Non-invasive respiratory support in the management of acute COVID-19 pneumonia: considerations for clinical practice and priorities for research – “The two randomized controlled trials indicate superiority of non-invasive ventilation over high-flow nasal
lundi, 22 novembre 2021 02:38 Écrit par Zouhair SouissiNon-invasive respiratory support in the management of acute COVID-19 pneumonia: considerations for clinical practice and priorities for research – The Lancet Respiratory Medicine Related: [Preprint] RCT: non-invasive respiratory strategies in acute respiratory failure in patients with COVID-19 – CPAP reduced the composite outcome of intubation or death within 30 days; high-flow nasal oxygenation was not associated […]
The post Non-invasive respiratory support in the management of acute COVID-19 pneumonia: considerations for clinical practice and priorities for research – “The two randomized controlled trials indicate superiority of non-invasive ventilation over high-flow nasal oxygen in reducing the need for intubation”. appeared first on Links Medicus.
EuGMS Guidance: Management of post-acute COVID-19 patients in geriatric rehabilitation.
lundi, 22 novembre 2021 02:38 Écrit par Zouhair SouissiManagement of post-acute COVID-19 patients in geriatric rehabilitation: EuGMS guidance – European Geriatric Medicine Related: Addressing Post-COVID Symptoms: A Guide for Primary Care Physicians. Global surveillance, research, and collaboration needed to improve understanding and management of long COVID. Provocative study suggests that persistent physical symptoms after COVID-19 infection may be associated more with the belief […]
The post EuGMS Guidance: Management of post-acute COVID-19 patients in geriatric rehabilitation. appeared first on Links Medicus.
